Once the dose and dose schedule has been confirmed, the dose expansion part of the study will open. The main purpose of the expansion part is to further assess the safety and tolerability, as well as preliminary anti-tumor activity, of the study treatment at the maximum tolerated dose and/or recommended dose for expansion. .